Dashboard
Strong Long Term Fundamental Strength with an average Return on Equity (ROE) of 12.84%
- Healthy long term growth as Operating profit has grown by an annual rate of 20.30%
The company has declared Positive results for the last 3 consecutive quarters
With ROE of 13.11%, it has a attractive valuation with a 3.57 Price to Book Value
High Institutional Holdings at 100%
Stock DNA
Capital Markets
USD 186,939 Million (Large Cap)
27.00
NA
24.61%
-999,999.00
14.73%
3.78
Total Returns (Price + Dividend) 
The Charles Schwab Corp. for the last several years.
Risk Adjusted Returns v/s 
News
Is The Charles Schwab Corp. overvalued or undervalued?
As of 7 November 2025, the valuation grade for The Charles Schwab Corp. moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 27, a PEG ratio of 0.86, and an EV to EBITDA ratio of 9.56, which are favorable compared to its peers. Notably, Morgan Stanley has a P/E of 18.52, while The Goldman Sachs Group, Inc. stands at 41.63, highlighting Schwab's relative attractiveness in the market. In terms of recent performance, The Charles Schwab Corp. has outperformed the S&P 500, with a year-to-date return of 29.14% compared to the index's 14.40%. This strong performance, combined with its attractive valuation metrics, reinforces the conclusion that the company is currently undervalued....
Read MoreIs The Charles Schwab Corp. overvalued or undervalued?
As of 7 November 2025, the valuation grade for The Charles Schwab Corp. has moved from fair to attractive, indicating a positive shift in its perceived value. The company appears to be undervalued, supported by a P/E ratio of 27, a PEG ratio of 0.86, and an EV to EBITDA ratio of 9.56, which are favorable compared to its peers. For instance, Morgan Stanley has a P/E of 18.52, while The Goldman Sachs Group, Inc. shows a significantly higher P/E of 41.63, highlighting Schwab's relative attractiveness in the market. In terms of recent performance, The Charles Schwab Corp. has outperformed the S&P 500 with a year-to-date return of 28.69% compared to the index's 14.40%, and a one-year return of 30.16% versus 12.65% for the S&P 500. This strong performance reinforces the valuation narrative, suggesting that the market may be underestimating the company's potential....
Read MoreIs The Charles Schwab Corp. overvalued or undervalued?
As of 7 November 2025, the valuation grade for The Charles Schwab Corp. has moved from fair to attractive, indicating a more favorable assessment of its market position. The company appears undervalued, supported by a P/E ratio of 27, a PEG ratio of 0.86, and an EV to EBITDA ratio of 9.56, which are competitive compared to its peers. For instance, Morgan Stanley has a P/E of 18.52, while The Goldman Sachs Group, Inc. stands at 41.63, highlighting Schwab's relative attractiveness in the capital markets sector. Additionally, The Charles Schwab Corp. has outperformed the S&P 500 with a year-to-date return of 28.69% compared to the index's 14.40%, and a one-year return of 30.16% versus 12.65% for the S&P 500. This performance reinforces the notion that the stock is undervalued relative to its growth potential and market performance....
Read More Announcements 
Corporate Actions 
Quality key factors 
Valuation key factors
Technicals key factors
Shareholding Snapshot : Jun 2025
Shareholding Compare (%holding) 
Domestic Funds
Held in 228 Schemes (34.23%)
Held by 512 Foreign Institutions (26.79%)
Quarterly Results Snapshot (Consolidated) - Jun'25 - QoQ
QoQ Growth in quarter ended Jun 2025 is 2.50% vs 0.02% in Mar 2025
QoQ Growth in quarter ended Jun 2025 is 11.37% vs 3.75% in Mar 2025
Annual Results Snapshot (Consolidated) - Dec'24
YoY Growth in year ended Dec 2024 is 1.87% vs 14.41% in Dec 2023
YoY Growth in year ended Dec 2024 is 17.27% vs -29.46% in Dec 2023






